The annual economic burden incurred by heart failure patients in Vietnam: a retrospective analysis.
Tien Duc DaoHien Thi Bich TranQuynh Van VuHuong Thi Thanh NguyenPol Van NguyenTrung Quang VoPublished in: Journal of pharmaceutical policy and practice (2024)
The study reveals that HF significantly impacts Vietnam's healthcare system and citizens, requiring a comprehensive understanding of its financial implications and efficient management of medical resources for those diagnosed. This study highlights the substantial economic burden of HF on Vietnam's healthcare system, with medication costs, particularly antithrombotic drugs, representing the largest expense. Most healthcare costs were covered by health insurance, and expenses were significantly influenced by comorbidity and length of hospital stay. These findings can inform healthcare policy, resource allocation and optimise management strategies in Vietnam.